Magnetic resonance spectroscopy of head and neck neoplasms

Topics in Magnetic Resonance Imaging

Volumn 15, Issue 2, 2004, Pages 87-94

  Shah, Gaurang V ^a,b   Gandhi, Dheeraj ^a   Mukherji, Suresh K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Head and neck cancer; Head and neck neoplasms; Magnetic resonance spectroscopy; Neck neoplasms; Squamous cell carcinoma

Indexed keywords

TUMOR MARKER;

BENIGN TUMOR; DIAGNOSTIC IMAGING; HEAD AND NECK TUMOR; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MONITORING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TUMOR RECURRENCE; TWO DIMENSIONAL CORRELATED SPECTROSCOPY;

CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL;

EID: 3342902791     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000130599.19502.ba     Document Type: Review

References (58)

1. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol. 1992;158:961-969.
2. Madison MT, Remley KB, Latchaw RE, et al. Radiologic diagnosis and staging of head and neck squamous cell carcinoma. Radiol Clin North Am. 1994;32:163-181.
3. Close LG, Merkel M, Vuitch MF, et al. Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx. Head Neck. 1989;11:309-317.
4. Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1997;39:841-848.
5. Brekel van den MWM, Castelijns JA, Croll GA, et al. Magnetic resonance imaging vs. palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg. 1991;117:663-673.
6. Van Dijke CF, Van Waes PF. Head and neck tumors, MRI versus CT: a technology assessment pilot study. Eur J Radiol. 1992;14:235-239.
7. Baba Y, Furusawa M, Murakami R, et al. Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:783-787.
8. Shah GV, Fischbein NJ, Patel R, et al. Newer magnetic resonance imaging techniques in head and neck. Magn Reson Imaging Clin North Am. 2003;11:449-469.
9. Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. Cancer Res. 1997;57:3398-3401.
10. Menard C, Smith ICP, Somorjai RL, et al. Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathological study of diagnostic validity. Int J Radiat Oncol Biol Phys. 2001;50:317-323.
11. Mountford CE, Tattersall MH. Proton magnetic resonance spectroscopy and tumor detection. Cancer Surv. 1987;6:285-314.
12. Somorjai RL, Dolenko B, Nikulin AK, et al. Classification of 1H MR spectra of human brain neoplasms: the influence of preprocessing and computerized consensus diagnosis on classification accuracy. J Magn Reson Imaging. 1996;6:437-444.
13. Mountford CE, Somorjai RL, Malycha P, et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analyzed using a statistical classification strategy. Br J Surg. 2001;88:1234-1240.
14. Bezabeh T, Somorjai RL, Smith ICP, et al. The use of 1H magnetic resonance spectroscopy in inflammatory bowel disease: distinguishing ulcerative colitis from Crohn's disease. Am J Gastroenterol. 2001;96:442-448.
15. Kuesel AC, Kroft T, Saunders JK, et al. A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies. Magn Reson Med. 1992;27:349-355.
16. Bezabeh T, Smith ICP, Krupnik E, et al. Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. Anticancer Res. 1996;16:1553-1558.
17. Somorjai RL, Nikulin AE, Pizzi N, et al. Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra I: application to 1H spectra of thyroid neoplasms. Magn Reson Med. 1995;33:257-263.
18. El-Sayed S, Bezabeh T, Odium O, et al. An ex-vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of head and neck region. Head Neck. 2002;24:766-772.
19. Mukherji SK, Kwock L, Schiro S. Magnetic resonance spectroscopy of the extracranial head and neck. In: Mukherji SK, ed. Clinical Applications of Magnetic Resonance Spectroscopy. New York: John Wiley & Sons; 1998.
20. Mukherji SK, Schiro S, Castillo M, et al. MR proton spectroscopy of squamous cell carcinoma of extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol. 1997;18:1057-1072.
21. Mukherji SK, Schiro S, Castillo M. Proton MRS of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol. 1996;17:1485-1490.
22. Mafee MF, Barany M, Gotsis ED, et al. Potential use of in vivo proton spectroscopy for head and neck lesions. Radiol Clin North Am. 1989;27:243-254.
23. Mukherji SK, Gerstle RJ. In vitro 1H MRS of squamous cell carcinoma of head and neck. Neuroimag Clin North Am. 1998;8:835-847.
24. Schiro S, Blackstock AW, Mukherji SK. New techniques in magnetic resonance spectroscopy: potential clinical applications. In: Mukherji SK, ed. Clinical MRS: Basic Principles and Applications. New York: John Wiley & Sons; 1998.
25. Fischbein N, Anzai Y, Mukherji SK. Application of new imaging technique for the evaluation of squamous cell carcinoma of the head and neck. Semin Ultrasound CTMR. 1999;20:187-212.
26. Miller BL. A review of chemical issues in 1-H NMRS: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 1991;4:47-52.
27. Kinoshita Y, Kajiwara H, Yokata A, et al. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery. 1994;35:606-614.
28. Thompson GA. Phospholipid metabolism in animal tissues. In: Ansell GB, Jawthorne JN, Dawson RMC, eds. Form and Function of Phospholipids. Amsterdam: Elsevier; 1973:67-96
29. Wurtman JJ. Sources of choline and lecithin in the diet. Nutri Brain. 1979;5:73-81.
30. Mountford CE, Wright LC, Holmes KT, et al. High resolution nuclear magnetic analysis of metastatic cancer cells. Science. 1984;226:1415.
31. Kuesel AC, Graschew G, Hull WE, et al. 31P NMR studies of cultured human tumor cells: influences of pH on phospholipid metabolite levels and the detection of CDP-choline. NMR Biomed. 1990;3:78-89.
32. Negendak WG, Brown TR, Evelhoch JL, et al. Proceedings of a national cancer institute workshop: MRS and tumor cell biology. Radiology. 1992;185:875-883.
33. Lean CL, MacKinnon WB, Delikatny J, et al. Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. Biochemistry (Mosc). 1992;31:11092-11105.
34. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992;5:226-233.
35. Mountford CE, Lean CL, Hancock R, et al. Magnetic resonance spectroscopy detects cancer in draining lymph nodes. Invasion & Metastasis. 1993;13:57-71.
36. De Cestaines JD, Larsen VA, Podo F, et al. In vivo P-31 MRS of experimental tumors. NMR Biomed. 1993;6:345-365.
37. Ross BD. The biochemistry of living tissues: examination by MRS. NMR Biomed. 1992;5:215-219.
38. Gill SG, Thomas DGT, Van Bruggen NV, et al. Proton MRS of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr. 1990;14:497-504.
39. Maheshwari SR, Mukherji SK, Neelon B, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MRS. AJNR Am J Neuroradiol. 2000;21:1930-1935.
40. Negendank W, Sauter R, Brown TR, et al. Proton magnetic spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg. 1996;84:449-458.
41. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MRS. AJNR Am J Neuroradiol. 1996;17:1-15.
42. Wang A, Sutton L, Cnann A, et al. Proton MRS of pediatric cerebellar tumors. AJNR Am J Neuroradiol. 1995;16:1821-1833.
43. Delikatny EJ, Russell P, Hunter JC, et al. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology. 1993;188:791-796.
44. Star-Lack JM, Adalsteinsson E, Adam MF, et al. In vivo 1H MRS of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol. 2000;21:183-193.
45. Okada A, Takehara H, Yoshida K, et al. Increased aspartate and glutamate levels in both gastric and colon cancer tissues. Tokushima J Exp Med. 1993;40:19-25.
46. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiographic appearance of the irradiated larynx: I. Expected changes. Radiology. 1994;193:141-148.
47. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiographic appearance of the irradiated larynx: II. Primary site response. Radiology. 1994;193:149-154.
48. Manara M. Histological changes of the human larynx irradiated with various technical therapeutic methods. Arch Ital Otolaryngol. 1966;79:596-635.
49. Mancuso AA, Mukherji SK, Schmalfuss I, et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol. 1999;17:631-637.
50. Spiro RH, Alfonso AE, Farr HW, et al. Cervical nodes metastasis from epidermoid carcinoma of oral cavity and oropharynx: a critical assessment of current staging. Am J Surg. 1974;128:562-567.
51. Huang W, Roche P, Shindo M, et al. Evaluation of head and neck tumor response to therapy using in vivo 1H MRS: correlation with pathology [Abstract]. Proc Intl Soc Magn Reson Med. 2000;8:552.
52. Bizzi A, Movsas B, Tedeschi G, et al. Response of non-Hodgkin lymphoma to radiation therapy: early and long term assessment with 1H MR spectroscopic imaging. Radiology. 1995;194:271-276.
53. Van Zijl PCM, Moonen CTW, Gillen J, et al. Proton magnetic resonance spectroscopy of small regions (1 mL) localized inside superficial human tumors: a clinical feasibility study. NMR Biomed. 1990;3:227-232,
54. Shukla-Dave A, Poptani H, Loevner LA, et al. Prediction of treatment response of head and neck cancers with P-31 MRS from pretreatment relative phosphomonoester levels. Acad Radiol. 2002;9:688-694.
55. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992;5:303-324.
56. McKenna WG, Lenkinski RE, Hendrix RA, et al. The use of magnetic resonance imaging and spectroscopy in the assessment of patients with head and neck and other superficial malignancies. Cancer. 1989;64:2069-2075.
57. Vogl T, Peer F, Schedel H, et al. 31-P spectroscopy of head and neck tumors-surface coil technique. Magn Reson Imag. 1989;7:425-435.
58. Hendrix RA, Lenkinski RE, Vogele K. BLOCH, mCkENNA wg. 31-p localized magnetic resonance spectroscopy of head and neck tumors: preliminary findings. Otolaryngol Head Neck Surg. 1990;103:775.